These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3957485)

  • 1. Determination of isoniazid half-life from salivary samples.
    Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):18-22. PubMed ID: 3957485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of metronidazole in saliva.
    Mustofa ; Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single sample saliva test to determine acetylator phenotype.
    Hutchings AD; Routledge PA
    Br J Clin Pharmacol; 1996 Nov; 42(5):635-7. PubMed ID: 8951197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
    Lammintausta K; Kangas L; Lammintausta R
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
    Hanson A; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A; Routledge PA
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
    Miscoria G; Leneveu A; Walle C; Roux A
    Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.
    Hutchings AD; Monie RD; Spragg BP; Routledge PA
    Br J Clin Pharmacol; 1988 May; 25(5):585-9. PubMed ID: 3408638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
    Caraco Y; Zylber-Katz E; Granit L; Levy M
    Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of free and N4-acetylated sulfapyridine concentrations in the plasma and saliva of man after sulfasalazine (salicylazosulfapyridine) administration: preliminary findings.
    Bates TR; Blumenthal HP; Pieniaszek HJ
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):183-9. PubMed ID: 9675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disopyramide concentrations in saliva.
    Aitio ML; Virtanen R; Lammintausta R
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):68-72. PubMed ID: 7061181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid pharmacokinetics in children according to acetylator phenotype.
    Rey E; Gendrel D; Treluyer JM; Tran A; Pariente-Khayat A; d'Athis P; Pons G
    Fundam Clin Pharmacol; 2001 Oct; 15(5):355-9. PubMed ID: 11903505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of acetylator phenotype of isoniazid by superimposed sinusodial tension polarography].
    Vallon JJ; Badinand A; Bichon C
    Eur J Toxicol Environ Hyg; 1976; 9(3):155-64. PubMed ID: 954852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation phenotype in rheumatoid arthritis.
    Oka M; Seppälä O
    Scand J Rheumatol; 1978; 7(1):29-30. PubMed ID: 675172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pefloxacin on urinary and salivary concentrations of isoniazid in six healthy female volunteers.
    Ofoefule SI; Onyeagba OE; Orisakwe OE
    Am J Ther; 2000 Sep; 7(5):313-6. PubMed ID: 11317177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.